Exciting Innovations in Pain Management with Saluda Medical

Exciting Innovations in Pain Management with Saluda Medical During the EVAlution event in Chicago, Dean Karantonis, PhD, highlighted a critical point: in spinal cord stimulation, precision is not just a feature; it’s the very foundation of effective treatment. With the groundbreaking Evoke® System featuring EVA™, this innovation scans and analyses each patient’s spinal cord at […]

Saluda Medical Appoints Jim Erickson as Chief Financial Officer

Link Here Minneapolis, Minnesota – December 14, 2023 – Saluda Medical, Inc. (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven advanced closed-loop technologies, today announced the appointment of Jim Erickson as Chief Financial Officer (CFO). “I am thrilled to welcome Jim to Saluda and believe his […]

Saluda Medical Announces $150M Equity Financing Led Wellington Management with Fidelity Management & Research Company and TPG

Financing Further Propels Commercial and Research & Development Initiatives Artarmon, NSW & Bloomington, MN – April 13, 2023, Link here – Saluda Medical Inc. (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced the […]

EVOKE Presentation Awarded Overall Winner at ASIPP Annual Meeting

Artarmon, Australia – Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation, today announced that the EVOKE 36-month Study received the Outstanding Achievement in Research Award at the 25th annual meeting of the American Society of Interventional Pain Physicians (ASIPP) in National Harbor, MD. The plenary session presentation titled […]

Saluda Medical Receives FDA Approval for the Evoke® Spinal Cord Stimulation System to Treat Chronic Intractable Pain

Link to full article Artarmon, Australia – March 8, 2022 – Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced it received full approval from the United States Food and […]

Saluda Medical Announces $125M Equity Financing Led Redmile Group LLC and New Investors Fidelity Management & Research Company LLC and T. Rowe Price Associates, Inc.

Link to full article March 2, 2022 – Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven advanced closed-loop technologies designed to treat debilitating neurological disorders, earlier this quarter finalized US $125 million in equity financing, led existing investor Redmile […]

Saluda Medical Appoints Doug Godshall as Chairman of the Board

Link to full article February 23, 2022 – Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company on a mission to revolutionize the field of neuromodulation with an emerging portfolio of therapies driven advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced the appointment of Doug Godshall as Chairman of its […]

Publication of Two-Year EVOKE Double-Blind Randomized Controlled Trial Results in JAMA Neurology Demonstrate Sustained Superiority of Evoke® Closed-Loop over Open-Loop Spinal Cord Stimulation

Link to full article Study shows Evoke ECAP-Controlled Closed-Loop Spinal Cord Stimulation provides superior outcomes with no explants due to loss of efficacy and near zero reprogramming burden long term January 10, 2022 – Saluda Medical Pty Limited (“Saluda Medical”), a global company on a mission to revolutionize the field of neuromodulation with an emerging portfolio […]